Mannkind (MNKD) Revenue (2010 - 2026)
Mannkind (MNKD) reported Revenue of $90.2 million for Q1 2026, up 15.08% year-over-year from $78.4 million in Q1 2025, and down 19.46% on a QoQ basis from $112.0 million in Q4 2025.
Mannkind (MNKD) has 14 years of Revenue data on file, last reported at $90.2 million in Q1 2026.
- Quarterly Revenue rose 15.08% year-over-year to $90.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $360.8 million (up 21.23% YoY) and the FY2025 annual result came in at $349.0 million, up 22.23% from the prior year.
- Revenue fell to $90.2 million in Q1 2026 per MNKD's latest filing, from $112.0 million in the prior quarter.
- Across five years, Revenue topped out at $112.0 million in Q4 2025 and bottomed at $300000.0 in Q2 2022.
- The 5-year median for Revenue is $66.3 million (2024), against an average of $59.1 million.
- The widest annual swing landed in 2022, when Revenue slumped 98.71%; it then soared 16103.67% in 2023.
- Tracing MNKD's Revenue over 5 years: stood at $36.1 million in 2022, then jumped by 62.16% to $58.5 million in 2023, then soared by 31.3% to $76.8 million in 2024, then soared by 45.82% to $112.0 million in 2025, then decreased by 19.46% to $90.2 million in 2026.
- Per Business Quant, the three latest MNKD Revenue figures stand at $90.2 million (Q1 2026), $112.0 million (Q4 2025), and $82.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 90.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90.17 Mn |
| Dec 31, 2025 | 111.96 Mn |
| Sep 30, 2025 | 82.13 Mn |
| Jun 30, 2025 | 76.53 Mn |
| Mar 31, 2025 | 78.35 Mn |
| Dec 31, 2024 | 76.78 Mn |
| Sep 30, 2024 | 70.08 Mn |
| Jun 30, 2024 | 72.39 Mn |
| Mar 31, 2024 | 66.26 Mn |
| Dec 31, 2023 | 58.47 Mn |
| Sep 30, 2023 | 51.25 Mn |
| Jun 30, 2023 | 48.61 Mn |
| Mar 31, 2023 | 40.63 Mn |
| Dec 31, 2022 | 36.06 Mn |
| Sep 30, 2022 | 32.83 Mn |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 11.99 Mn |
| Dec 31, 2021 | 12.52 Mn |
| Sep 30, 2021 | 22.21 Mn |
| Jun 30, 2021 | 23.28 Mn |
| Mar 31, 2021 | 17.44 Mn |
| Dec 31, 2020 | 18.44 Mn |
| Sep 30, 2020 | 15.35 Mn |
| Jun 30, 2020 | 200,000.00 |
| Mar 31, 2020 | 16.24 Mn |
| Dec 31, 2019 | 15.99 Mn |
| Sep 30, 2019 | 700,000.00 |
| Jun 30, 2019 | 200,000.00 |
| Mar 31, 2019 | 17.45 Mn |
| Dec 31, 2018 | 16.03 Mn |
| Sep 30, 2018 | 4.47 Mn |
| Jun 30, 2018 | 3.89 Mn |
| Mar 31, 2018 | 3.47 Mn |
| Dec 31, 2017 | 4.53 Mn |
| Sep 30, 2017 | 2.04 Mn |
| Jun 30, 2017 | 2.16 Mn |
| Mar 31, 2017 | 3.01 Mn |
| Dec 31, 2016 | 12.40 Mn |
| Sep 30, 2016 | 162.35 Mn |
| Sep 30, 2012 | 35,000.00 |
| Mar 31, 2011 | 50,000.00 |
| Jun 30, 2010 | 93,000.00 |